Female Fertility and Pregnancy Rapid Test Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos
Global female fertility and pregnancy rapid test market
is expected to register a CAGR of around 5% over the period of 2021-2027.
This is mainly due to the rising female aging population, surging number of
infertility cases, growing hormonal disorders, and rising awareness regarding female
fertility and pregnancy rapid test devices coupled with the growing focus of
major stakeholders in the beauty industry to adopt to make beauty products more
sustainable with and eco-friendlier. Major healthcare companies are investing
heavily in their products due to the growing average age of first-time
pregnancy has increased drastically across the globe. According to CDC, in
2019, about 6% of married women aged 15-44 years in the United States were
unable to conceive after one year of trying. Moreover, about 12% of women aged
15-44 years in the United States have difficulty conceiving or sustaining a
pregnancy. Furthermore, various factors such as hormonal imbalance can cause
disorders such as PCOS (polycystic ovary syndrome), indescribable miscarriages,
and the emergence of advanced ovulation monitors, which are responsible for
excessive use of female fertility and pregnancy rapid tests. Therefore, the
market for female fertility and pregnancy rapid tests is expected to witness
significant growth during the forecast period.
Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21037
According to UnivDatos Market Insights (UMI)’ research report
“global female fertility and pregnancy rapid test market”, the market is
expected to witness robust growth during the forecast period 2021-2027F.
This is mainly due to the increasing aging population and fast and self-contained
tests, and awareness regarding the safety of women’s health among consumers.
For Instance, in June 2021, BioMerieux announced the distribution of specific
diagnostics’ REVEAL Rapid AST system in Europe which strengthen the rapid
testing kits segment of the market in the European region. The specific reveal
rapid AST system delivers phenotypic AST results in an average of 5 hours,
directly from positive blood culture. Thus, with the growing focus on
technology the specific reveal is easy to use, has high throughput, and
provides accurate minimum inhibitory concentration (MIC) results with wide
antimicrobial coverage. Furthermore, REVEAL Rapid AST offers customers an
easy-to-use instrument with a targeted menu, small footprint, and modular
design well-suited for a large number of hospitals.
Based on device type, the market is classified into digital
devices and line-indicator devices. Amongst types, the line-indicator devices
category accounted for a significant share of the market. This is mainly due to
the presence of a wide range of products and the advent of novel and improved
methods that include mid-stream devices, strip/dipsticks, and cassettes. Thus,
these medical devices have a method of test format is another factor that can
influence the accuracy of pregnancy tests when used at home, their demand is
increasing across the globe. Over the forthcoming years, the rising popularity
of home-based diagnostic testing products among the younger generation is
likely to boost the demand for female fertility and pregnancy rapid tests
remarkably, worldwide.
Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21037
Based on product, the market is categorized into fertility
rapid test kits and pregnancy rapid test kits. Among these, the pregnancy rapid
test kits are expected to witness the highest CAGR during the forecast period.
The pregnancy rapid test kits are growing the number of adolescent pregnancies
and are expected to support the growth of the segment over the forecast period.
According to the Centers for Disease Control, one in eight couples has trouble
conceiving or sustaining a pregnancy, due to age, health issues, or other
factors. This indicates that there is a need in the market for cost-efficient
and accurate ovulation monitors.
North America to witness extensive growth
For a better understanding of the market adoption of the female fertility
and pregnancy rapid test industry, the market is analyzed based on its
worldwide presence in the countries such as North America (US, Canada, Rest of
North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe);
Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest
of World. North America is expected to witness a significant CAGR during the
forecast period on account of growing various devices, the rise in first-time
pregnancy age, and the availability of less time-consuming decentralized
diagnostic tests in place of laboratory tests have boosted the market growth.
The increased consumer awareness regarding the availability of various
fertility as well as pregnancy rapid test kits. Furthermore, the increasing
prevalence of gynecological disorders and infertility and fast and
self-contained tests, new product launches, and various developmental
strategies adopted by the regional market will drive market growth.
For more informative information, please visit us – https://univdatos.com/report/female-fertility-and-pregnancy-rapid-test-market/
According to UnivDatos Market Insights (UMI)’, the key players with a
considerable market share in the global Female fertility and pregnancy rapid
test market are BioMerieux, Abbott, Church & Dwight, Quidel, Clinical
Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, and Mankind
Pharma are some of the key players in the market. Several M&As along with
partnerships have been undertaken by these players to boost their presence in
different regions.
“Global Female Fertility and Pregnancy Rapid Test Market”
provides comprehensive qualitative and quantitative insights on the industry
potential, key factors impacting sales and purchase decisions, hotspots, and
opportunities available for the market players. Moreover, the report also
encompasses the key strategic imperatives for success for competitors along
with strategic factorial indexing measuring competitors’ capabilities on
different parameters. This will help companies in the formulation of
go-to-market strategies and identifying the blue ocean for its
offerings.
For more informative information, please visit us – https://univdatos.com/report/female-fertility-and-pregnancy-rapid-test-market/
Market Segmentation:
- By Device Type (Digital Devices and Line-indicator Devices)
- By Test Type (FSH Urine Test, LH Urine Test, hCG Blood Test, and hCG Urine
Test)
- By Product (Fertility Rapid Test Kits and Pregnancy Rapid Test Kits)
- By Distribution Channel (Retail Stores, Online Stores, Gynecology and Fertility
Clinics, and Other)
- By Region (North America, Europe, Asia-Pacific, Rest of the World)
- By Company (BioMerieux, Abbott, Church & Dwight, Quidel, Clinical
Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, and
Mankind Pharma)
Key questions answered in the study:
- What are the current and future trends of the global female
fertility and pregnancy rapid test industry?
- How the industry has been evolving in terms of technology and
application?
- How the competition has been shaping across the countries
followed by their comparative factorial indexing?
- What are the key growth drivers and challenges for the global
female fertility and pregnancy rapid test industry?
- What is the customer orientation, purchase behavior, and
expectations from the global female fertility and pregnancy rapid test
suppliers across various region and countries?
Table of Content –
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 GLOBAL FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET COVID-19 IMPACT
6 GLOBAL FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET REVENUE (USD BN),
2019-2027F
7 MARKET INSIGHTS BY DEVICE TYPE
8 MARKET INSIGHTS BY TEST TYPE
9 MARKET INSIGHTS BY PRODUCT
10 MARKET INSIGHTS BY DISTRIBUTION CHANNEL
11 MARKET INSIGHTS BY REGION
12 FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET DYNAMICS
13 FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET OPPORTUNITIES
14 FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET TRENDS
15 POLICY & REGULATORY FRAMEWORK
16 DEMAND AND SUPPLY-SIDE ANALYSIS
17 VALUE CHAIN ANALYSIS
18 COMPETITIVE SCENARIO
19 COMPANY PROFILED
20 DISCLAIMER
Browse Other Related Research Reports from UnivDatos Market Insights
- Cancer
Immunotherapy Market: Current Analysis and Forecast 2021-2027
- 3D
Bioprinting of Living Human Tissues/Organs Market is growing by leaps and
bounds with Top Key players like 3Dynamic Systems, Aspect Biosystems,
Allevi, BioDan
- Lack
of Donors Driving the Wearable Artificial Organs Market: Current Analysis
and Forecast with Different Segments, Key Players Insights
- Mobile
Health Application (mHealth Apps) Market to Reach US$ 315.4 Billion by
2027, Globally |CAGR: 44.4%
Labels: Female Fertility
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home